In a good news for those who find it hard to kick the butt, a new vaccine which would help them quit smoking would soon be available in the market.
This will be the second all-party meeting called by the government to discuss the COVID-19 situation since the outbreak of the pandemic.
Health Minister Ghulam Nabi Azad, who is on a four-day visit to China, met his counterpart Chen Zhu in Beijing and sought his intervention to expedite clearance for Indian pharmaceutical companies.
"We have decided to send officials from both sides to sit on table either in New Delhi or Moscow to remove the bottlenecks, including clinical trials of new drugs," Azad told the Indian media after meeting his Russian counterpart Tatiana Golikova.
Government on Tuesday said an indigenous Indian vaccine for H1N1 would be ready by the beginning of April, even as it demanded an inquiry into the 'panic' created by international bodies on the scale of the epidemic.
Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.
Inspections only in domestic authorities' presence, visiting US drug regulator told
The American Association of Physicians of Indian Origin will attend the Pravasi Bharatiya Divas in Delhi with an agenda to develop a plan to bring together AAPI, NGOs and the government to provide access to affordable and quality health care. Aziz Haniffa reports
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances